Download accelerated approval for breakthrough therapies

Paul Kemp CEO & CSO Intercytex joined us last year at the World Stem Cells & Regenerative Medicine Congress to present on ‘Accelerated approval for breakthrough therapies: streamlining clinical development.’ Download this presentation now to find out more about: Current Licensing system Conditional Approval Licensing Progressive Translation ICX-RHY / VAVELTA ICX-RHY Medical applications: EB …And much more about the approval! …

Orphan drugs, no longer orphan?

Have orphan drugs found a home? It seems that this is the case for a lot of rare disease therapies being developed, as pharma and biotechs, along with investors, have understood that producing orphan drugs can be a potent money maker. It all started with the first orphan drug approved by the FDA from Genzyme to treat Gaucher's Disease and …